Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II, Open Label Study to Assess the Safety and Efficacy Autologous Bone Marrow-derived Mesenchymal Stromal Cells Seeded on to Decellularised Airway Scaffold in Subjects with Clinically Significant Bronchopleural Fistula

NCT04435249 is registered in ClinicalTrials.gov with Videregen Limited as lead sponsor.

NCT NCT04435249
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04435249 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II, Open Label Study to Assess the Safety and Efficacy Autologous Bone Marrow-derived Mesenchymal Stromal Cells Seeded on to Decellularised Airway Scaffold in Subjects with Clinically Significant Bronchopleural Fistula
Lead sponsor
Videregen Limited
Phase
Phase 1/2
Overall status
Withdrawn
Start date
October 31, 2025
Completion date
November 30, 2028
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

bronchopleural fistula